Pharmaceutical Technology

APRIL 21, 2023

US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The US Food and Drug Administration granted approval to Entadfi for the treatment of BPH in December 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 24, 2022

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Vaccines 91

STAT

NOVEMBER 18, 2022

… Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports.  A Or you may want to take stock of your life. But be safe. Enjoy, and see you soon.

Diabetes 246

Diabetes Documentation Biosimilars Compounding 246

pharmaphorum

JANUARY 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. which helped to make the shots after being urged to do so by the US government, the Biden administration in March 2021 hailing the collaboration ‘historic’.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. This is a significant increase compared to the 2021–20 season when the rate was 28.3 per 100,000.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.

Vaccines 52

Vaccines Nursing Homes Communication Pharmaceutical Companies 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes 87

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 87

Pharma Marketing Network

JANUARY 6, 2021

Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

MARCH 31, 2021

Another recent change is the timelier release of scientific information; rather than holding on to clinical trial findings until the ‘perfect’ opportunity to present them at a major congress, 2020 increasingly saw pharmaceutical companies make data public in real time. Conclusion.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

FEBRUARY 16, 2022

Leela Barham and Neil Grubert look back at what was expected for market access in 2021 and look ahead at what 2022 could hold. MHRA gave first Project Orbis approvals in 2021 followed by mixed success for access deals. The 1 January 2021 saw the UK’s regulator, the MHRA, formally join Project Orbis.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

Immunity 58

Immunity Immunization Diabetes Pharmaceutical Companies 58

Express Pharma

APRIL 6, 2023

Pharmaceutical companies have a high tendency to outsource the finished dose manufacture of new molecular entities (NME). Approvals of five regenerative medicines made 2022 the most successful year ever for these medicines – following on from the strong performance in 2021.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

MAY 26, 2021

“People I think are open to their health data being shared if they are asked, but once you start to talk about commercial access for pharmaceutical companies or large tech companies, that trust starts to erode very quickly,” she added. — Foxglove (@Foxglovelegal) May 26, 2021.

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

pharmaphorum

DECEMBER 15, 2020

There is a long-established synergistic relationship between larger, “innovation-driven” pharmaceutical companies and the generics industry in ensuring supply of established, but nevertheless essential, medicines. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies.

Generic Medicine 93

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 93

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

pharmaphorum

NOVEMBER 27, 2022

To combat such challenges, pharmaceutical companies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceutical companies can ensure drug production runs smoothly – even under stress.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

APRIL 30, 2021

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

PharmaShots

APRIL 12, 2023

The company's mRNA platform comprises advances across three components, i.e., mRNA, delivery, and the manufacturing process. Moderna's 2022 revenue increased by 0.04% vs. 2021. Merck KGaA's 2022 revenue depicted an inclination of 6.56% vs. 2021. Novo's 2022 revenue increased by 0.18% vs. 2021.

Diabetes 64

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

NOVEMBER 16, 2022

J&J rose from third to second place on the back of research in areas like TB, HIV, Ebola, and intestinal worms, while AZ took the final podium position – up from seventh in 2021 – in part because it is the top performer on product delivery. Jayasree Iyer.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

Pharmaceutical Technology

JUNE 4, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Hospitals 105

Hospitals Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 104

European Pharmaceutical Review

MARCH 11, 2024

Employing MALDI-TOF MS for microbial identification in sterile drug manufacturing Fungal contamination in pharmaceutical cleaning facilities Case study examples Mould and yeast have been reported by several previous authors in numerous pharmaceutical cleanrooms , cold rooms, and controlled areas, according to the authors. Ahmed et al.

Sterile Compounds 98

Sterile Compounds Compounding Packaging Pharmaceutical Companies 98

Pharmaceutical Technology

JUNE 4, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Mayo Clinic 98

Mayo Clinic Hospitals Pharmaceutical Companies Pharmaceutical Companies 98

PharmaShots

FEBRUARY 21, 2023

Market Cap: $21.06M Founded Year: 2021 Total Employees: ~10 Headquarters: Victoria, Australia Stock Exchange: ASX Radiopharm Theranostics is a biotech company focused on developing radiopharmaceuticals for diagnosing and treating diseases with high unmet medical needs. In 2021, Xofigo generated a sale of $75.08M.

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Food and Drug Administration (FDA) in June 2021. 2021, June 7). 2021, December 8). 2021, September 1).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Vaccines 52

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

PharmaShots

APRIL 25, 2023

Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunity 56

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Vaccines 64

PharmaShots

MARCH 9, 2023

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Other Affiliations: She is a fellow of the Royal Society (May 2021) associated with Merck.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Diabetes Vaccines 40

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Diabetes Vaccines 40

pharmaphorum

APRIL 27, 2022

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Especially, women tend to have more distrust in pharmaceutical companies.

Vaccines 98

Vaccines Drug Pricing Diabetes Pharmaceutical Companies 98

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 59